On December 01, we had the opportunity to set up the first ATMP supply chain event in Niel in partnership with At.las. This first event allowed us to highlight the challenges but also some of the solutions for the ATMP sector, Cell&Gene. Different participants from the whole value chain were…
We are pleased to announce the organization of the next BSMA (Bio Supply Management Alliance) Europe conference on October 28th 2021 in Brussels (La Hulpe) Biolog Consulting is proud to contribute to the sharing of knowledge and collaboration between industry players in order to advance health globally. We will have…
When the COVID-19 pandemic broke out in early 2020, a number of players turned to us remembering that the supply chain had an important role to play in this crisis. Since then, we can say that we have been at the forefront of finding solutions, building, planning, and quickly growing…
Sometimes ghostly, sometimes real, the Brexit deal seems to have materialized in recent hours subject to close agreement from the British parliament. But what can be the impacts of this deal from a supply chain, logistics or general operations point of view? What does the agreement really contain? – End…
Biolog Consulting was glad to take part to the 4th BSMA Europe conference in La Hulpe. As organizer of the event and co founder of BSMA Europe, Franck Toussaint delivered a key message on collaboration across the industry. It was also the opportunity to give some industry trends for the…
Do you need to send human cells and tissue to a partner in Europe? Do you want to export these tissues from your laboratory in Europe to a laboratory in a third country or vice versa? To do this, it is necessary to know and follow the rules established by…
The Supply Chain is a complex ecosystem where many different actors, often with diverging interests, interact. The blockchain brings these actors together by offering everyone end-to-end visibility of the expeditions. Examples of blockchain include: The classical cryptocurrency – Bitcoin The protection of private data on a state level The optimization…
Transport for medical emergencies requires perfect control of the supply chain. The slightest mistake by one of the actors can have vital consequences for patients. For transplants, the request is made in advance. This is not to the nearest fifteen minutes, but to the nearest hour. Current conservation requirements prescribe…
By obtaining the GDP certification, you demonstrate to your stakeholders that you are able to provide good quality products, as pharmaceutical manufacturers expect, and thus serve the healthcare sector as an indispensable partner in the healthcare supply chain. What are GDP Guidelines? GDP are a quality system for…
On October 11th, Franck Toussaint will participate to the BSMA conference in Foster City. At this occasion he will be part of a panel discussion on “Handling the Tumultuous Global Economic and Political Uncertainties” This very intersting panel discussion will be the occasion to exchange with peers such as Khalid…
We are proudly organizing and be present at BSMA Europe annual conference and launch in Brussels on May 19th (Dolce la hulpe). A unique opportunity to build the future of Life Sciences industry. About the event: The Bio supply chain management alliance is a community of life sciences supply chain…
November 27th, 2017 was supposed to be the start of the new serialization policy under DSCSA. But last June 30th, FDA issued a draft guidance for the industry & product identifier requirements. DSCSA – drug supply chain and security act to apply to all companies. On that day FDA delayed…
